Kelsey A. Manko

Kelsey A. Manko

Auto-generated profile, based on publicly available information

Kelsey A. Manko

College of Medicine, University of Central Florida, Orlando, FL, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2020 in FEBS Open Bio
Verified
Journal Article
Open access
PDF file
CLChengcheng Li
Chengcheng Li
DVDorianmarie Vargas‐Franco
Dorianmarie Vargas‐Franco
MSMadhurima Saha
Madhurima Saha
RDRachel M. Davis
Rachel M. Davis
KMKelsey A. Manko
Kelsey A. Manko
PKPeter B. Kang
Peter B. Kang
Biallelic loss‐of‐function MEGF10 mutations lead to MEGF10 myopathy, also known as early onset myopathy with areflexia, respiratory distress, and dysphagia (EMARDD). MEGF10 is expressed in muscle satellite cells, but the contribution of satellite cell dysfunction to MEGF10 myopathy is unclear. Myofibers and satellite cells were isolated and examined from Megf10−/− and wild‐type mice. A separate set of mice underwent repeated intramuscular barium chloride injections. Megf10−/− muscle satellite cells showed reduced proliferation and migration, while Megf10−/− mouse skeletal muscles showed impaired regeneration. Megf10 deficiency is associated with impaired muscle regeneration, due in part to defects in satellite cell function. Efforts to rescue Megf10 deficiency will have therapeutic implications for MEGF10 myopathy and other inherited muscle diseases involving impaired muscle regeneration.

2 February 2025 in Journal of Endometriosis and Pelvic Pain Disorders
Verified
Journal Article
Closed access
KMKelsey Manko
Kelsey Manko
CAChristana O. Ajewole
Christana O. Ajewole
HLHannah Lewis
Hannah Lewis
SBStefanie Barish
Stefanie Barish
GLGeorgine Lamvu
Georgine Lamvu
Background: Few studies describe the healthcare expectations and experiences of persons living with chronic pelvic pain (CPP), despite its prevalence. Objectives: To describe pain symptoms, impact, interference with quality of life, treatment goals, treatments tried, and satisfaction with treatments and healthcare professionals among persons with CPP and determine whether these characteristics vary by pain duration (<6 months vs. ⩾6 months). Design: Cross-sectional population survey. Methods/Participants/Setting: Survey distributed to US persons ⩾18 years old. Results: Of 1,118 completed respondents, 69.8% ( n = 780) reported abdominal/pelvic pain and a pain level ⩾2 on a 0–10 scale. Of those, 122 respondents had pelvic pain lasting <6 months, while 658 had pain ⩾6 months (categorized as having CPP.) Compared to those with pain <6 months, persons with CPP were more likely to have severe pain that interfered with relationships ( p = 0.001), sleep ( p = 0.042), enjoyment of life ( p = 0.004), mood ( p = 0.019), and normal daily activity ( p =0.035). They were more likely to have pain that impacted sexual function ( p = 0.001) and ability to raise a family ( p = 0.035) and were more likely to report receiving conflicting information from healthcare professionals (HCPs) ( p = 0.001). In both groups, few were satisfied (very—somewhat satisfied categories combined) with care (34.9% vs. 38.6%, p = 0.332) and treatment (33.9% vs. 27.1%, p = 0.355). Limitations: Survey with close-ended questions. Conclusion: Individuals with abdomino-pelvic pain, particularly those with chronic pain, experience significant pain and disability, but many report receiving inadequate treatment or unsatisfactory care. This suggests there is still a need for improved healthcare services that address the unique needs of this population.